 Methodology: Following informed consent patients are randomized in a 1:1 fashion to influenza vaccination or placebo from 24 hours prior to coronary angiographyPCI NSTEMI patients to 72 hours following coronary angiographyPCI NSTEMI and STEMI patients. 